| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |